Relative imbalance between T regulatory cells and activated T cells in mice with differential morbidity in chronic Schistosoma mansoni infections

Parasite Immunology

Volumn 31, Issue 8, 2009, Pages 440-446

  Watanabe, K ^a,b   Carter, J M ^a   Neely Burnam, M ^a   Colley, D G ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Activated T cells; Chronic; Morbidity; Schistosomiasis; T regulatory cells

Indexed keywords

ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONIC DISEASE; CONTROLLED STUDY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; MORBIDITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SPLEEN CELL; SPLENOMEGALY;

ANIMALS; ANTIGENS, CD3; ANTIGENS, HELMINTH; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; GRANULOMA; INTERFERON-GAMMA; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED CBA; SCHISTOSOMIASIS MANSONI; SPLEEN; SPLENOMEGALY; T-LYMPHOCYTES, REGULATORY;

MUS; SCHISTOSOMA MANSONI;

EID: 68249162069     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01127.x     Document Type: Article

References (46)

1. King CH Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008 4 : 65 79.
2. Vennervald BJ Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004 17 : 439 447.
3. Caldas IR, Campi-Azevedo AC, Oliveira LF, et al. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop 2008 108 : 109 117.
4. Silveira AM, Gazzinelli G, Alves-Oliveira LF, et al. Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg 2004 98 : 514 519.
5. Lehman JS Jr., Mott KE, Morrow RH Jr., Muniz TM Boyer MH. The intensity and effects of infection with Schistosoma mansoni in a rural community in northeast Brazil. Am J Trop Med Hyg 1976 25 : 285 294.
6. Arap Siongok TK, Mahmoud AA, Ouma JH, et al. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg 1976 25 : 273 284.
7. De Jesus AR, Magalhaes A, Miranda DG, et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 2004 72 : 3391 3397.
8. Rodrigues V Jr., Piper K, Couissinier-Paris P, et al. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect Immun 1999 67 : 4689 4692.
9. Dessein AJ, Hillaire D, Elwali NE, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 1999 65 : 709 721.
10. Muller-Myhsok B, Stelma FF, Guisse-Sow F, et al. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 1997 61 : 452 454.
11. Marquet S, Abel L, Hillaire D, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996 14 : 181 184.
12. Hirayama K, Matsushita S, Kikuchi I, et al. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 1987 327 : 426 430.
13. Salam EA, Ishaac S Mahmoud AA. Histocompatibilty-linked susceptibility for hepatospleenomegaly in human schistosomiasis mansoni. J Immunol 1979 123 : 1829 1831.
14. Rutitzky LI, Hernandez HJ, Yim YS, et al. Enhanced egg-induced immunopathology correlates with high IFN-gamma in murine schistosomiasis: identification of two epistatic genetic intervals. J Immunol 2005 174 : 435 440.
15. Shainheit MG, Smith PM, Bazzone LE, et al. Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology. J Immunol 2008 181 : 8559 8567.
16. Henderson GS, Nix NA, Montesano MA, et al. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol 1993 142 : 703 714.
17. Falcao PL, Malaquias LC, Martins-Filho OA, et al. Human schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol 1998 20 : 447 454.
18. Taylor JJ, Mohrs M Pearce EJ. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006 176 : 5839 5847.
19. Baumgart M, Tompkins F, Leng J Hesse M. Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006 176 : 5374 5387.
20. Singh KP, Gerard HC, Hudson AP, Reddy TR Boros DL. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 2005 114 : 410 417.
21. McKee AS Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004 173 : 1224 1231.
22. Watanabe K, Mwinzi PN, Black CL, et al. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg 2007 77 : 676 682.
23. Cetre-Sossah CB, Montesano MA, Freeman GL Jr., et al. Early responses associated with chronic pathology in murine schistosomiasis. Parasite Immunol 2007 29 : 241 249.
24. Colley DG, Sasser LE Reed AM. PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity. Parasite Immunol 2005 27 : 45 53.
25. Montesano MA, Colley DG, Eloi-Santos S, Freeman GL Jr. Secor WE. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J Exp Med 1999 189 : 637 645.
26. Montesano MA, Freeman GL Jr., Secor WE Colley DG. Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections. J Immunol 1997 158 : 3800 3804.
27. Bosshardt SC, Freeman GL Jr., Secor WE Colley DG. IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunol 1997 19 : 347 353.
28. Freeman GL Jr., Montesano MA, Secor WE, et al. Immunopathogenesis and immunoregulation in schistosomiasis. Distinct chronic pathologic syndromes in CBA/J mice. Ann NY Acad Sci 1996 797 : 151 165.
29. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 : 8 27.
30. Cavassani KA, Campanelli AP, Moreira AP, et al. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol 2006 177 : 5811 5818.
31. Hisaeda H, Hamano S, Mitoma-Obata C, et al. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection. Eur J Immunol 2005 35 : 3516 3524.
32. Boros DL Warren KS. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970 132 : 488 507.
33. Hori S, Nomura T Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
34. Pearce EJ MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002 2 : 499 511.
35. Hesse M, Modolell M, La Flamme AC, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001 167 : 6533 6544.
36. Fallon PG, Richardson EJ, McKenzie GJ McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000 164 : 2585 2591.
37. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008 214 : 199 210.
38. Kaviratne M, Hesse M, Leusink M, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 2004 173 : 4020 4029.
39. Wynn TA, Thompson RW, Cheever AW Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004 201 : 156 167.
40. Wynn TA, Eltoum I, Oswald IP, Cheever AW Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994 179 : 1551 1561.
41. Hoffmann KF, Cheever AW Wynn TA. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000 164 : 6406 6416.
42. Jankovic D, Cheever AW, Kullberg MC, et al. CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med 1998 187 : 619 629.
43. Walsh CM, Smith P Fallon PG. Role for CTLA-4 but not CD25+ T cells during Schistosoma mansoni infection of mice. Parasite Immunol 2007 29 : 293 308.
44. Chevillard C, Moukoko CE, Elwali NE, et al. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003 171 : 5596 5601.
45. Mallat A, Preaux AM, Blazejewski S, et al. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 1995 21 : 1003 1010.
46. Colley DG. Adoptive suppression of granuloma formation. J Exp Med 1976 143 : 696 700.